Table 3.
PEDro score for methodological quality assessment of including studies.
| Reference | Item 1 | Item 2 | Item 3 | Item 4 | Item 5 | Item 6 | Item 7 | Item 8 | Item 9 | Item 10 | Item 11 | score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shen XY et al. (48) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5/10 |
| Wu F et al. (46) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6/10 |
| Lam P et al. (44) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5/10 |
| Li ZB et al. (34) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5/10 |
| Meng E (49) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6/10 |
| Wang P et al. (47) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6/10 |
| Wei DL (33) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6/10 |
| Ahn S (40) | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3/10 |
| Chen SC et al. (32) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5/10 |
| Trang T et al. (35) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6/10 |
| Cai H (42) | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 4/10 |
| Chen ZC (52) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 5/10 |
| Li HC et al. (50) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5/10 |
| Bao QW et al. (53) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6/10 |
| Zhao G et al. (45) | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 6/10 |
| Youngwanichsetha S et al. (43) | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 7/10 |
| Kan Y et al. (51) | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 5/10 |
| Wang JH et al. (41) | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 4/10 |
Item 1, eligibility criteria; item 2, random allocation; item 3, concealed allocation; item 4, similar baseline; item 5, subjected blinded; item 6, therapists blinded; item 7, assessors blinded; item 8, < 15% dropouts; item 9, intention-to-treat analysis; item 10, between-group comparison; item 11, point measures and variability data; 1, described explicitly and in details; 0, unclear, inadequately described.